Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2012
05/17/2012US20120122786 Use of Polypeptide Micromolecule MLIF in Preparing Medicine for Preventing and Treating Myocardial Ischemia
05/17/2012US20120122784 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
05/17/2012US20120122780 Compounds, Compositions and Methods for Modulating Uric Acid Levels
05/17/2012US20120122777 Diagnostic agent for ischemic heart disease risk group
05/17/2012US20120122776 Dpp-iv inhibitors for treatment of diabetes in pediatric patients
05/17/2012US20120122773 N-substituted-cyclic amino derivative
05/17/2012US20120122771 STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/17/2012US20120122766 Novel Polypeptide Having Angiogenesis-Inducing Activity And Antibacterial Activity, And Use Thereof For Medical Purposes
05/17/2012US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120122763 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
05/17/2012US20120122762 186 Human Secreted Proteins
05/17/2012US20120122109 Neural progenitor cells derived from embryonic stem cells
05/17/2012US20120121732 Composition for Use in the Prevention and Treatment of Cardiovascular Diseases
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121724 Film comprising therapeutic agents
05/17/2012US20120121720 Modulation of Beta 2 Adrenergic Receptors by Inhibitors of EGLN3 or pVHL
05/17/2012US20120121719 Methods of making and using three-dimensional extracellular matrices
05/17/2012US20120121711 Microsphere drug carrier, preparation method, composition and use thereof
05/17/2012US20120121699 Lycopene and resveratrol dietary supplement
05/17/2012US20120121698 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
05/17/2012US20120121689 Small interfering rna delivery
05/17/2012US20120121684 Coating Comprising A Poly(Ethylene Glycol)-Poly(Lactide-Glycolide-Caprolactone) Interpenetrating Network
05/17/2012US20120121668 Compositions for oral adminstration of active principles requiring masking of taste
05/17/2012US20120121605 Anti sulfatides and anti sufated proteoglycans antibodies and their use
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121590 Methods of inhibiting adverse cardiac events and treating atherosclerosis and coronary artery disease using galectin-3 binding protein (gal-3bp, btbd17b, mac-2 binding protein)
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease
05/17/2012US20120121579 Treatment of oncostatin m receptor beta mediated heart failure
05/17/2012US20120121573 Treatment of Pulmonary Vascular Remodeling With Neprilysin
05/17/2012US20120121559 Treatment and prevention of pathological conditions using iduna related techniques and compositions
05/17/2012US20120121557 Neuregulin induced proliferation of cardiomyocytes
05/17/2012US20120121556 Methods of using regenerative cells to promote wound healing
05/17/2012US20120121554 Hmg-coa secondary metabolites and uses thereof
05/17/2012US20120121542 Red-shifted opsin molecules and uses thereof
05/17/2012US20120121530 Vasoprotective and cardioprotective antidiabetic therapy
05/17/2012US20120121527 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
05/16/2012EP2453010A1 Neural progenitor cells derived from embryonic stem cells
05/16/2012EP2453009A1 Methods of organ regeneration
05/16/2012EP2452939A2 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
05/16/2012EP2452690A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor
05/16/2012EP2452683A2 Methods for treating atherosclerosis
05/16/2012EP2452679A1 Cytoprotective agent
05/16/2012EP2451816A1 Crystalline form of prasugrel hydrobromide, preparation and application thereof
05/16/2012EP2451782A1 Dual-acting pyrazole antihypertensive agents
05/16/2012EP2303251B1 New combination for use in the treatment of inflammatory disorders
05/16/2012EP2268625B1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
05/16/2012EP1990052B1 Pharmaceutical package comprising 2-ethoxy-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1h-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl or 2-cyclopropyl-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1h-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl and a desiccant.
05/16/2012EP1786428B1 Pde5 inhibitor compositions and methods for treating cardiac indications
05/16/2012EP1480993B2 Desaturase genes, enzymes encoded thereby, and uses thereof
05/16/2012CN1668763B 1L1RL-1 as a cardiovascular disease marker and therapeutic target
05/16/2012CN102460175A STRUCTURE OF THE C-TERMINAL REGION OF THE INSULIN RECEPTOR a-CHAIN AND OF THE INSULIN-LIKE GROWTH FACTOR RECEPTOR a-CHAIN
05/16/2012CN102459599A Nucleic acid modulators of glycoprotein vi
05/16/2012CN102459588A Aptamer for chymase, and use thereof
05/16/2012CN102459272A 对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法 Selective for P110δ bicyclic pyrimidine compounds and methods of use for the PI3K inhibitor
05/16/2012CN102459247A 作为醛固酮合酶抑制剂的苯并噁唑酮衍生物 As aldosterone synthase inhibitors benzoxazole derivatives
05/16/2012CN102459244A 喹唑啉二酮衍生物、其制备及其多种治疗用途 Quinazoline dione derivatives, their preparation and their therapeutic uses multiple
05/16/2012CN102459221A 噻吩衍生物 Thiophene derivative
05/16/2012CN102459220A 治疗心血管疾病的组合物及其方法 Composition for treatment of cardiovascular diseases and methods
05/16/2012CN102459218A 凝集素样氧化型ldl受体抑制用医药品以及动脉硬化预防医药品 Lectin-like oxidized ldl receptor inhibition with pharmaceuticals pharmaceuticals and atherosclerosis prevention
05/16/2012CN102459215A 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
05/16/2012CN102459198A Crystals
05/16/2012CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists
05/16/2012CN102459146A 制备苯并呋喃的方法 Method for preparing benzofuran
05/16/2012CN102459142A Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
05/16/2012CN102458428A Nfat signal inhibitor and calcineurin inhibitor
05/16/2012CN102458415A Bifidobacteria for treating diabetes and related conditions
05/16/2012CN102458409A Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
05/16/2012CN102458401A Therapeutic agent for hypertension or normal high blood pressure
05/16/2012CN102458399A Novel therapeutic treatments using centhaquin
05/16/2012CN102458394A Treatment or prophylaxis of proliferative conditions
05/16/2012CN102453757A Application of micro RNA and antisense nucleic acid thereof in diagnosis, prevention, treatment and/or prognosis evaluation of myocardial ischemic injury
05/16/2012CN102453715A Small molecular interfering RNA for glioma angiogenesis resistance with high efficiency, preparation method and application thereof
05/16/2012CN102453661A Formula of health-care wine and making method thereof
05/16/2012CN102453654A Antihypertensive drug wine
05/16/2012CN102451472A Application of minimal heterodimer partner in blood lipid regulation
05/16/2012CN102451465A Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction
05/16/2012CN102451449A Capsule for warming channel to remove coldness
05/16/2012CN102451443A Recipe for treating gynecological inflammation and preparation process of recipe
05/16/2012CN102451427A Heart nursing pellets
05/16/2012CN102451422A Traditional Chinese medicinal foot-bath lotion
05/16/2012CN102451389A Traditional Chinese medicine composition for treating hypertension
05/16/2012CN102451366A Anti-arrhythmia traditional Chinese medicine capsule
05/16/2012CN102451353A External washing medicament for treating hemorrhoid
05/16/2012CN102451333A Method of extracting water-soluble saponin from yellow ginger
05/16/2012CN102451329A Blood circulation promoting and blood stasis removing wine
05/16/2012CN102451320A Traditional Chinese medicine for treating hypertension
05/16/2012CN102451313A Preparation method of medicinal umbilical paste for treating apoplexy sequelae
05/16/2012CN102451307A Traditional Chinese medicine for treating heart disease
05/16/2012CN102451303A Blood circulation promoting and blood stasis removing peach kernel wine
05/16/2012CN102451302A Preparation method of Chinese medicinal prescription for treating hemorrhoids
05/16/2012CN102451292A Formula of drinking water for treating high blood pressure, and preparation method thereof
05/16/2012CN102451283A Varicose vein dredging capsules
05/16/2012CN102451279A Formula of water agent for treating high blood pressure, and manufacture method thereof
05/16/2012CN102451267A Traditional Chinese medicine for treating hypertensive heart disease
05/16/2012CN102451232A Chinese medicinal preparation for treating angina pectoris
05/16/2012CN102451231A Chinese medicinal preparation for treating coronary heart disease angina and preparation method thereof
05/16/2012CN102451230A Preparation method for red sage root decoction pieces
05/16/2012CN102451222A Brain-tonifying stasis-clearing powder
1 ... 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 ... 1595